http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_5cfda391b44c84337309d4bca54988a0
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Hamamoto |
| name | Ryuji Hamamoto |
| given-name | Ryuji |
| organization-name | Department of Medicine, University of Chicago, Chicago, IL, USA Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo and 2Laboratory for Biomarker Development, Center for Genomic Medicine, RIKEN, Tokyo, Japan; 3First Department of Internal Medicine, Sapporo Medical University, Sapporo, Japan; 4Department of Surgery, Osaka Medical Center for Cancer and Cardiovascular Diseases, Osaka, Japan; and 5CRBM, Universites Montpellier 2 and 1, Centre National de la Recherche Scientifique, Montpellier, France Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan; and Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, University of Tokyo, Tokyo 108-8639, Japan; Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan. 3Department of Medicine, Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois. Division of Molecular Modification and Cancer Biology, National Cancer Center, Tokyo, Japan. Department of Medicine, University of Chicago, Chicago, Illinois, USA Section of Hematology/Oncology, Department of Medicine, The University of Chicago, MC2115 Chicago, IL 60637, USA 1Section of Hematology and Oncology, University of Chicago, Chicago, Illinois. Division of Molecular Modification and Cancer Biology, National Cancer Center, Tokyo, Japan Division of Medical AI Research and Development National Cancer Center Research Institute Tokyo Japan 1Laboratory of Molecular Medicine, Human Genome Center and Section of Hematology/Oncology Department of Medicine The University of Chicago Chicago Illinois USA Division of Molecular Modification and Cancer Biology, National Cancer Center, Tokyo 104‑0045, Japan Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project Center, RIKEN. Division of Medical AI Research and Development National Cancer Center Research Institute Tokyo Japan; Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project Tokyo Japan Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, 5-1-1 Tsukiji, Chuo-ku, Tokyo 104-0045 Japan, rhamamot@ncc.go.jp. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo 104‑0045, Japan Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo; 2Laboratory for Biomarker Development, RIKEN, Minato-ku; 3Department of Surgery, Kyorin University School of Medicine, Mitaka; 4Division of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo; 5Biomolecular Characterization Team, RIKEN, Wako, Saitama; 6Laboratory for Medical Informatics, RIKEN, Yokohama, Kanagawa, Japan; Departments of 7Genetics and 8Oncology, Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge; 9Institute of Ophthalmology, University College London, London, United Kingdom; and 10Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois; Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo; 2Laboratory for Biomarker Development, RIKEN, Minato-ku; 3Department of Surgery, Kyorin University School of Medicine, Mitaka; 4Division of Colorectal Surgery, National Cancer Center Hospital, Chuo-ku, Tokyo; 5Biomolecular Characterization Team, RIKEN, Wako, Saitama; 6Laboratory for Medical Informatics, RIKEN, Yokohama, Kanagawa, Japan; Departments of 7Genetics and 8Oncology, Cancer Research UK, Cambridge Research Institute, University of Cambridge, Cambridge; 9Institute of Ophthalmology, University College London, London, United Kingdom; and 10Section of Hematology/Oncology, The University of Chicago, Chicago, Illinois Department of Medicine, The University of Chicago, Chicago, IL, USA Laboratory of Genome Technology, Human Genome Center, Institute of Medical Science, The University of Tokyo, Tokyo, Japan. Division of Medical AI Research and Development, National Cancer Center Research Institute. Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo, Japan Division Chief in the Division of Medical AI Research and Development, National Cancer Center Research Institute; a Professor in the Department of NCC Cancer Science, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University and a Team Leader of the Cancer Translational Research Team, RIKEN Center for Advanced Intelligence Project Section of Hematology/Oncology, Department of Medicine, The University of Chicago, MC2115, Chicago, IL 60637, USA Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL, USA Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center; 2Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo; 3Department of Surgery and Science, Graduate School of Medical Science, Kyusyu University, Maidashi, Higashi-ku, Fukuoka; 4Laboratory for Medical Informatics, RIKEN, Suehirocho, Tsurumi-ku, Yokohama, Kanagawa, Japan; 5Department of Oncology, Cancer Research UK Cambridge Research Institute; 6Department of Genetics, University of Cambridge; and 7Division of Surgery & Interventional Science, UCL Medical School, University College London, London, United Kingdom; Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center; 2Division of Clinical Immunology, Advanced Clinical Research Center, Institute of Medical Science, The University of Tokyo, Shirokanedai, Minato-ku, Tokyo; 3Department of Surgery and Science, Graduate School of Medical Science, Kyusyu University, Maidashi, Higashi-ku, Fukuoka; 4Laboratory for Medical Informatics, RIKEN, Suehirocho, Tsurumi-ku, Yokohama, Kanagawa, Japan; 5Department of Oncology, Cancer Research UK Cambridge Research Institute; 6Department of Genetics, University of Cambridge; and 7Division of Surgery & Interventional Science, UCL Medical School, University College London, London, United Kingdom Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan; 2Biomolecular Characterization Team, RIKEN and CREST, Wako, Saitama, Japan; 3Laboratory for Biomarker Development, RIKEN, Minato-ku, Tokyo, Japan; 4Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; 5Department of Genetics, University of Cambridge, Cambridge, United Kingdom; and 6Department of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge, Cambridge, United Kingdom; Authors' Affiliations: 1Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Minato-ku, Tokyo, Japan; 2Biomolecular Characterization Team, RIKEN and CREST, Wako, Saitama, Japan; 3Laboratory for Biomarker Development, RIKEN, Minato-ku, Tokyo, Japan; 4Developmental and Molecular Pathways, Novartis Institutes for BioMedical Research, Cambridge, Massachusetts; 5Department of Genetics, University of Cambridge, Cambridge, United Kingdom; and 6Department of Oncology, Cancer Research UK Cambridge Research Institute, University of Cambridge, Cambridge, United Kingdom Division of Medical AI Research and Development National Cancer Center Research Institute Tokyo Japan; Cancer Translational Research Team RIKEN Center for Advanced Intelligence Project Tokyo Japan Division of Molecular Modification and Cancer Biology National Cancer Center Tokyo Japan Division of Molecular Modification and Cancer Biology, National Cancer Center , Tokyo 104-0045, Japan Section of Hematology/Oncology Department of Medicine The University of Chicago Chicago Illinois USA; Division of Molecular Modification and Cancer Biology National Cancer Center Research Institute Tokyo Japan Division of Medical AI Research and Development, National Cancer Center Research Institute Section of Hematology/Oncology, Department of Medicine, The University of Chicago, 5841 S. Maryland Ave, MC2115 Chicago, IL 60637, USA Section of Hematology/Oncology Department of Medicine The University of Chicago 5841 S. Maryland Ave, MC2115 Chicago Illinois 60637 Division of Medical AI Research and Development, National Cancer Center Research Institute, Tokyo 104‑0045, Japan Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA Division of Molecular Modification and Cancer Biology, National Cancer Center Research Institute, Tokyo 104-0045, Japan National Cancer Center Research Institute Division of Molecular Modification and Cancer Biology Tokyo Japan; RIKEN Center for Advanced Intelligence Project Tokyo Japan Section of Hematology/Oncology, Department of Medicine, The University of Chicago, Chicago, IL 60637, USA; Division of Molecular Modification and Cancer Biology, National Cancer Center, Chuo-ku, Tokyo 104-0045, Japan |
Incoming Links
Total number of triples: 174.